THE 5-SECOND TRICK FOR MBL77

Not all people with CLL need therapy. Even with all recent innovations, the iwCLL still suggests watchful observation for people with asymptomatic disorder.86 This suggestion is based on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of thos